Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies, Inc. reports developments tied to its nuclear manufacturing, engineering, and services businesses for government and commercial customers. Recurring updates include U.S. Naval Nuclear Propulsion Program contracts, long-lead reactor and component manufacturing, commercial nuclear equipment, and work connected to nuclear fuel and uranium-enrichment capabilities.
Company news also covers operating and financial results for its Government Operations and Commercial Operations segments, capital actions, governance changes, and regulatory engagement involving nuclear licensing. BWXT’s recurring business themes span global security, clean energy, nuclear medicine, space exploration, and environmental restoration.
BWX Technologies (BWXT) has been awarded a contract by the U.S. Department of Energy’s National Nuclear Security Administration to deliver a conceptual design for the first module of a new Lithium Processing Facility at the Y-12 National Security Complex.
The phase one contract is a four-month, $4 million effort focused on the facility’s Machining and Inspection Module. BWXT will work with partners Edgewater Technical Associates, Evans General Contractors, Process Engineering Associates and Merrick & Co. Two companies were selected through a competitive process, and NNSA plans to evaluate both designs before down-selecting one team for subsequent construction contract negotiations.
BWX Technologies (NYSE: BWXT) will host an Investor Day for financial analysts and institutional investors on Tuesday, September 29, 2026, starting at 8:30 a.m. EDT in New York City. The event will feature presentations by senior leadership, a live Q&A session and a webcast on the company’s Investor Relations website, with materials and replay available online.
BWX Technologies (NYSE: BWXT) announced that the U.S. Army selected its BWXT Advanced Nuclear Reactor (BANR) microreactor technology for deployment under the Janus next‑generation nuclear energy program, led with the Defense Innovation Unit. The first BANR is planned for the Fort Campbell Army installation on the Kentucky‑Tennessee border.
According to BWX Technologies, the Janus program will follow a phased contracting approach. Initial work includes final site selection within Fort Campbell, starting Army nuclear regulatory processes, and beginning TRISO fuel fabrication at existing BWX Technologies facilities. The company is targeting groundbreaking in late 2028 and reactor operations in the early 2030s, alongside work on operating company structure, site characterization and supply chain preparation.
BWX Technologies (NYSE: BWXT) has appointed Suzanne Maddux as senior vice president, operations, a newly created role reporting to President and CEO Rex Geveden. The position is intended to support BWXT’s growth in nuclear national security and commercial nuclear power markets.
Maddux will lead Environmental Health and Safety, Security, Operational Excellence and Supply Chain, and oversee manufacturing operations, engineering and quality. A key mandate is to strengthen connections between BWXT’s Government Operations and Commercial Operations to share learning and replicate proven practices. She joins from Mercury Systems, previously spending 18 years at RTX in senior operations-related roles.
BWX Technologies (NYSE: BWXT) reported second quarter 2026 revenue of $901.6 million, up 18% year over year, with Government Operations at $601.3 million (+2%) and Commercial Operations at $302.5 million (+72%). GAAP net income was $89.1 million and adjusted EBITDA reached $155.5 million, both higher than 2025.
Diluted GAAP EPS was $0.97 and non-GAAP EPS $1.07, up 14% and 5%, respectively. Free cash flow was $115.0 million, down 9% on higher capital expenditures of $41.4 million. BWXT announced the sale of its medical business and closed the acquisition of Precision Components Group on July 1, 2026 to expand U.S. commercial nuclear manufacturing. The company raised its 2026 guidance to revenue of about $3.8 billion, adjusted EBITDA of $662–$672 million, non-GAAP EPS of $4.70–$4.80, and free cash flow of $345–$360 million.
BWX Technologies (NYSE: BWXT) has signed a definitive agreement to sell its medical business to healthcare-focused investor Nordic Capital in a transaction valued at up to $800 million. The deal includes BWXT Medical and Kinectrics’ stable medical isotopes business, with BWXT retaining a meaningful minority stake in the new company.
According to BWX Technologies, the sale is intended to free capital and management resources to accelerate growth in its core nuclear national security and commercial nuclear power markets. BWXT will continue to provide specialized isotope and radiochemical expertise to the divested business. Management noted that since acquiring the medical unit in 2018, BWXT has roughly tripled its revenue, improved profitability and broadened its product portfolio with therapeutic isotopes. The transaction remains subject to customary regulatory approvals and is expected to close by the end of 2026.
BWX Technologies (NYSE: BWXT) has completed its acquisition of Precision Components Group (PCG), including Precision Custom Components and DC Fabricators.
The deal adds over 500,000 square feet of U.S. heavy nuclear manufacturing capacity, a workforce of 450+ employees, and strengthens BWXT’s commercial and U.S. Navy nuclear components capabilities.
BWX Technologies (NYSE: BWXT) will release its second quarter 2026 financial results on Monday, August 3, 2026, after market close, followed by a conference call at 5:00 p.m. EDT.
Investors can join via webcast at investors.bwxt.com or by phone using the provided U.S. and international dial-in numbers.
ATI (NYSE: ATI) signed a new five-year strategic material supply agreement with BWX Technologies (NYSE: BWXT), extending their support for the U.S. Naval Nuclear Propulsion Program through fiscal 2030.
ATI will provide specialty materials for nuclear applications, leveraging decades of defense and materials science expertise.
BWX Technologies (NYSE: BWXT) reported that its TRISO nuclear fuel powered Antares Nuclear’s reactor to the first successful criticality under Executive Order 14301 reforming DOE reactor testing.
BWXT also processed HALEU feedstock from NNSA scrap and continues ongoing TRISO manufacturing for Antares, highlighting scalable U.S. advanced reactor fuel capabilities.